Abstract
Glucocorticoids are the most widely used drugs for the treatment of hypersensitivity, however these drugs themselves and the excipients contained in commercial corticosteroid formulations are able to induce severe immediate-type hypersensitivity reactions. Reactions involving excipients have been confirmed to be IgE mediated by the demonstration of specific-IgE to excipients such as carboxymethylcellulose and lactose. In case of hypersensitivity reactions to corticosteroid preparations, a complete allergy work-up with skin tests and/or challenge tests should include testing excipients as well as the active ingredients.
Keywords: Anaphylaxis, carboxymethylcellulose, excipients, glucocorticoids, hypersensitivity, lactose, macrogols, povidone.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:Hypersensitivity Reactions from Excipients in Systemic Glucocorticoid Formulations
Volume: 15 Issue: 2
Author(s): Gianfranco Calogiuri, Lene H. Garvey, Paolo Romita, Luigi Macchia and Caterina Foti
Affiliation:
Keywords: Anaphylaxis, carboxymethylcellulose, excipients, glucocorticoids, hypersensitivity, lactose, macrogols, povidone.
Abstract: Glucocorticoids are the most widely used drugs for the treatment of hypersensitivity, however these drugs themselves and the excipients contained in commercial corticosteroid formulations are able to induce severe immediate-type hypersensitivity reactions. Reactions involving excipients have been confirmed to be IgE mediated by the demonstration of specific-IgE to excipients such as carboxymethylcellulose and lactose. In case of hypersensitivity reactions to corticosteroid preparations, a complete allergy work-up with skin tests and/or challenge tests should include testing excipients as well as the active ingredients.
Export Options
About this article
Cite this article as:
Calogiuri Gianfranco, Garvey H. Lene, Romita Paolo, Macchia Luigi and Foti Caterina, Hypersensitivity Reactions from Excipients in Systemic Glucocorticoid Formulations, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2016; 15 (2) . https://dx.doi.org/10.2174/1871523016666161109144021
DOI https://dx.doi.org/10.2174/1871523016666161109144021 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical and Forensic Signs Related to Cocaine Abuse
Current Drug Abuse Reviews Hypersensitivity Reactions to Ophthalmic Products
Current Pharmaceutical Design Could Additional Inhibitors of the Renin -Angiotensin System be Clinically Useful?
Current Hypertension Reviews Emerging Biologics in the Treatment of Inflammatory Bowel Disease: What is Around the Corner?
Current Drug Targets Advances in the Development of Bradykinin Receptor Ligands
Current Topics in Medicinal Chemistry Safety of Dipeptidyl Peptidase 4 Inhibitors for Treatment of Type 2 Diabetes
Current Drug Safety New Insights on the Possible Role of Mast Cells in Aspirin-Induced Asthma
Current Molecular Pharmacology Structure Function Analysis of Serpin Super-Family: "A Computational Approach"
Protein & Peptide Letters Neuro-AIDS: Current Status and Challenges to Antiretroviral Drug Therapy (ART) for Its Treatment
Current Drug Therapy Mast Cell Disorders In Drug Hypersensitivity
Current Pharmaceutical Design Life Threatening and Fatal Contrast Media Reactions: Pathomechanisms, Diagnosis, Prevention and Drug Management
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Factors Associated with Self-Reported Drug Allergies in a Large Chronic Spontaneous Urticaria Cohort
Current Drug Safety Immunotoxicity and Immunogenicity of Biopharmaceuticals: Design Concepts and Safety Assessment
Current Drug Safety Hymenoptera Venom Proteins and Peptides for Diagnosis and Treatment of Venom Allergic Patients
Inflammation & Allergy - Drug Targets (Discontinued) Extracellular Proteases as Targets for Drug Development
Current Protein & Peptide Science Cow’s Milk Allergy in Children, from Avoidance to Tolerance
Endocrine, Metabolic & Immune Disorders - Drug Targets Target Product Selection - Where Can Molecular Pharming Make the Difference?
Current Pharmaceutical Design Genes and Hypertension
Current Pharmaceutical Design Design of Multifunctional Compounds for Cardiovascular Disease: From Natural Scaffolds to “Classical” Multitarget Approach
Current Medicinal Chemistry Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety